Insiders BeOne Medicines AG

Equities

ONC

US07725L1026

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 01:30:00 06/06/2026 am IST			5-day change	1st Jan Change
270.10 ^USD	-3.51%		-6.19%	-11.10%

02/06	BeOne Medicines Solid Tumor Data Boost Confidence in Long-term Growth, RBC Says	MT
02/06	RBC Raises Price Target on BeOne Medicines to $436 From $425, Keeps Outperform Rating	MT

Insiders

17/04	BeOne Medicines AG Announces Board and Committee Changes	CI
15/01	BeOne CEO on Business Strategy, Biotech Outlook	MT
18/12	BeOne Medicines Ltd. Appoints Lai Wang as President, Global Head of Research and Development, Effective January 1, 2026	CI
01/25/01	Beone Medicines Insider Sold Shares Worth $280,233, According to a Recent SEC Filing	MT
26/25/26	Beone Medicines Insider Sold Shares Worth $830,360, According to a Recent SEC Filing	MT
07/25/07	Beigene Insider Sold Shares Worth $2,073,826, According to a Recent SEC Filing	MT
06/25/06	Beigene Insider Sold Shares Worth $24,674,638, According to a Recent SEC Filing	MT
04/25/04	Beigene Insider Sold Shares Worth $331,375, According to a Recent SEC Filing	MT
27/25/27	BeiGene, Ltd. Announces Management Changes	CI
21/25/21	BeiGene Insider Sold Shares Worth $12,485,045, According to a Recent SEC Filing	MT
07/25/07	Beigene Insider Sold Shares Worth $9,424,955, According to a Recent SEC Filing	MT
20/25/20	Beigene, Ltd. Announces Board and Committee Changes	CI
09/25/09	Beigene Insider Sold Shares Worth $7,370,515, According to a Recent SEC Filing	MT
06/25/06	BeiGene, Ltd. Announces Appointment of Giancarlo Benelli as Senior Vice President and Head of Europe	CI
13/24/13	Beigene Insider Sold Shares Worth $7,805,106, According to a Recent SEC Filing	MT
02/24/02	BeiGene Insider Sold Shares Worth $9,190,570, According to a Recent SEC Filing	MT
28/24/28	BeiGene, Ltd. Announces Passing Away of Donald Glazer, A Board Member and the Chair of the Nominating and Corporate Governance Committee	CI
11/24/11	Beigene Insider Sold Shares Worth $3,756,092, According to a Recent SEC Filing	MT
26/24/26	BeiGene, Ltd. Appoints Shalini Sharp to Board of Directors and Member of the Audit Committee, Effective September 27, 2024	CI
18/24/18	Beigene, Ltd. Appoints Aaron Rosenberg as the Principal Financial Officer, Effective from July 22, 2024	CI
27/24/27	Beigene Insider Sold Shares Worth $445,070, According to a Recent SEC Filing	MT
21/24/21	Beigene Insider Sold Shares Worth $368,162, According to a Recent SEC Filing	MT
21/24/21	BeiGene, Ltd. Announces Executive Changes	CI
15/24/15	Beigene Insider Sold Shares Worth $8,368,017, According to a Recent SEC Filing	MT
23/24/23	Beigene, Ltd. Announces Board Changes	CI